FDA Approval of Takeda's Orzeyful Marks a Shift in Narcolepsy Treatment
The FDA has approved Takeda's Orzeyful, a new orexin receptor agonist that promises to improve daytime alertness for narcolepsy patients.
August 05, 2026
Finance
Financial news, markets, and business updates
Scrutiny Grows on Chinese Gene-Editing Trials Following Child's Death
A child’s death in a CRISPR gene-editing trial by HuidaGene raises serious concerns about safety and regulatory oversight in China’s biotech sector.
August 05, 2026
Moderna Initiates First Clinical Trial for Ebola mRNA Vaccine
Moderna has launched a clinical trial for its mRNA-based Ebola vaccine, marking a significant step in combating this viral disease.
August 05, 2026
Reassessing AI Potential: Insights from Schrödinger’s CEO Ramy Farid
Ramy Farid of Schrödinger reflects on the evolving role of AI in biotech, envisioning clearer perceptions in the industry within five years.
August 05, 2026
Medicare Pilot and Pharma Developments: Key Updates on Orphan Drugs and Merger Talks
A recent Medicare pilot proposal risks reducing savings for retail drugs. Meanwhile, merger talks between AstraZeneca and Bristol Myers Squibb have been denied.
August 05, 2026
Impact of Excluding Rare Disease Treatments from Medicare Drug Pricing Pilots
Excluding rare disease therapies from Medicare's drug pricing pilots could significantly reduce overall savings, according to recent research.
August 05, 2026
Rethinking Prostate Cancer Diagnosis: The Role of MRI vs. Traditional Methods
Despite high diagnosis rates, many U.S. men miss out on MRI screenings for prostate cancer, which could lead to better outcomes.
August 05, 2026
Novo Nordisk's Heart Drug Fails to Reduce Major Cardiac Events in Key Trial
Novo Nordisk's ziltivekimab, aimed at targeting inflammation, showed no reduction in cardiovascular events despite lowering inflammation markers.
July 31, 2026
The American Diabetes Association's Shift from Courage to Controversy
The American Diabetes Association, once praised for its bravery, now faces criticism for its handling of dissent within the medical community.
July 31, 2026
Research and Challenges in San Diego's Fight Against Syphilis Spread
In San Diego, a surge in syphilis cases highlights the challenges researchers face amid a drug shortage and complex patient interactions.
July 31, 2026
Capricor's FDA Hearing: Scrutiny Amid Leadership Changes and Industry Challenges
Capricor Therapeutics faces skepticism over its Duchenne MD therapy data, while the biotech sector grapples with leadership turmoil and FDA scrutiny.
July 30, 2026
FDA Panel Rejects Duchenne Treatment as FTC Targets Hims & Hers Practices
A recent FDA panel's critical vote against a Duchenne drug highlights ongoing scrutiny of digital health practices, particularly Hims & Hers.
July 30, 2026
Latigo Biotherapeutics Shows Promise with Non-Opioid Pain Relief Drug in Phase 2 Trial
Latigo Biotherapeutics' LTG-001 demonstrates significant pain relief in Phase 2 trials, marking a potential shift in non-opioid pain management options.
July 29, 2026
FTC Targets Hims for Misleading Practices and Privacy Violations
The FTC has initiated a lawsuit against Hims & Hers, accusing the telehealth firm of deceptive practices in consumer health data handling.
July 29, 2026
Democrats Capitalize on Medicare Drug Subsidy Cuts Amid Rising Costs
The end of Medicare drug subsidies is set to elevate out-of-pocket costs for older adults, providing Democrats with a potent campaign issue for the midterms.
July 29, 2026
Biotech Executive's Secret Identity and Legal Battle Over Eli Lilly's Pricing Policies
A fugitive assumed a new life in biotech, while a New Hampshire hospital challenges Eli Lilly's controversial pricing policies under the 340B program.
July 29, 2026
Trusting Clinical AI: A Showdown Between Clinical and Generalist Models
A recent study reveals clinical AI models underperform compared to generalist models, sparking debate in the health AI community.
July 29, 2026
Mysterious Biotech Figure's History of Concealment Raises Questions on Hiring Practices
The revelation of a fugitive's secret biotech career sparks scrutiny over hiring practices and vetting processes in the industry.
July 29, 2026
The Decline of Space Horror Films: Exploring the Genre's Shift to Earth
Despite a horror renaissance, space horror films have faded from Hollywood. Explore why the genre isn't taking off again on the cinematic stage.
July 26, 2026
Michael Foale Reflects on the 1997 Mir Collision: A Tale of Heroism and Responsibility
In an exclusive interview, astronaut Michael Foale shares his experiences during the 1997 Mir space station collision and the challenges that followed.
July 25, 2026